Adenovirus-mediated overexpression of p15(INK4B) inhibits human glioma cell growth, induces replicative senescence, and inhibits telomerase activity similarly to p16(INK4A)

Cell Growth and Differentiation

Volumn 11, Issue 7, 2000, Pages 373-384

  Fuxe, Jonas ^a   Akusjärvi, Göran ^b   Goike, Helena M ^a   Roos, Göran ^c   Collins, V Peter ^a,d   Pettersson, Ralf F ^a  

^a LUDWIG INSTITUTE FOR CANCER RESEARCH   (Sweden)

^b UPPSALA UNIVERSITY   (Sweden)

^c UMEÅ UNIVERSITY   (Sweden)

^d ADDENBROOKE S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P15; PROTEIN P16; RETINOBLASTOMA PROTEIN; TELOMERASE;

ARTICLE; CANCER INHIBITION; CELL CYCLE; CELL GROWTH; ENZYME INHIBITION; GENE OVEREXPRESSION; GENETIC TRANSDUCTION; GLIOBLASTOMA; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; SENESCENCE; TUMOR SUPPRESSOR GENE;

ADENOVIRIDAE; CARRIER PROTEINS; CELL AGING; CELL CYCLE PROTEINS; CELL DIVISION; CELL LINE; CELL SIZE; CYCLIN D1; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P15; CYCLIN-DEPENDENT KINASE INHIBITOR P16; CYCLIN-DEPENDENT KINASES; ENZYME INDUCTION; GLIOMA; HUMANS; IMMUNOBLOTTING; MUTATION; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RECOMBINANT PROTEINS; RETINOBLASTOMA PROTEIN; TELOMERASE; TRANSFECTION; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53; TUMOR SUPPRESSOR PROTEINS;

EID: 0342656549     PISSN: 10449523     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Hunter, T., and Pines, J. Cyclin D and CDK inhibitors come of age. Cell, 79: 573-582, 1994.
2. Sherr, C. Cancer cell cycles. Science (Washington DC), 274: 1672-1677, 1996.
3. Weinberg, R. The retinoblastoma protein and cell cycle control. Cell, 81: 323-330, 1995.
4. 1 cyclin-dependent kinases. Genes Dev., 9: 1149-1163, 1995.
5. Serrano, M., Hannon, G., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature (Lond.), 366: 704-707, 1993.
6. Xiong, Y., Zhang, H., and Beach, D. Subunit rearrangement of the cyclin-dependent kinases is associated with cellular transformation. Genes Dev., 7: 1572-1583, 1993.
7. INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature (Lond.), 371: 257-261, 1994.
8. INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function. Genes Dev., 8: 2939-2952, 1994.
9. Hirai, H., Roussel, M., Kato, J., Ashmun, R., and Sherr, C. Novel INK4 proteins, p19 and p18, are specific inhibitors of the cyclin D-dependent kinases CDK4 and CDK6. Mol. Cell. Biol., 15: 2672-2681, 1995.
10. INK4. Mol. Cell. Biol., 15: 2682-2688, 1995.
11. Hall, M., Bates, S., and Peters, G. Evidence for different modes of action of cyclin-dependent kinase inhibitors: p15 and p16 bind to kinases, p21 and p27 bind to cyclins. Oncogene, 11: 1581-1588, 1995.
12. Kamb, A. Cell-cycle regulators and cancer. Trends Genet., 11: 136-140, 1995.
13. Hall, M., and Peters, G. Genetic alterations of cyclins, cyclin-dependent kinases, and Cdk inhibitors in human cancer. Adv. Cancer Res., 68: 67-108, 1996.
14. Kamb, A., Gruis, N., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S., Stockert, E., Day, R., III, Johnson, B., and Skolnick, M. A cell cycle regulator potentially involved in genesis of many tumor types. Science (Washington DC), 264: 436-440, 1994.
15. Nobori, T., Miura, K., Wu, D., Lois, A., Takabayashi, K., and Carson, D. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature (Lond.), 368: 753-756, 1994.
16. Cairns, P., Polascik, T., Eby, Y., Tokino, K., Califano, J., Merlo, A., Mao, L., Herath, J., Jenkins, R., Westra, W., Rutter, J. L., Buckler, A., Gabrielson, E., Tockman, M., Cho, K. R., Hedrick, L., Bova, G. S., Isaacs, W., Koch, W., Schwab, D., and Sidransky, D. Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nature Genet., 11: 210-212, 1995.
17. Hirama, T., and Koeffler, H. Role of the cyclin-dependent kinase inhibitors in the development of cancer. Blood, 86: 841-854, 1995.
18. Jen, J., Harper, J., Bigner, S., Bigner, D., Papadopoulos, N., Markowitz, S., Willson, J., Kinzler, K., and Vogelstein, B. Deletion of p16 and p15 genes in brain tumors. Cancer Res., 54: 6353-6358, 1994.
19. Schmidt, E., Ichimura, K., Reifenberger, G., and Collins, V. CDKN2 (p16/MTS1) gene deletion or CDK4 amplification occurs in the majority of glioblastomas. Cancer Res., 54: 6321-6324, 1994.
20. Schmidt, E., Ichimura, K., Messerle, K., Goike, H., and Collins, V. Infrequent methylation of CDKN2A(MTS1/p16) and rare mutation of both CDKN2A and CDKN2B(MTS2/p15) in primary astrocytic tumours. Br. J. Cancer, 75: 2-8, 1997.
21. INK4 expression is frequent in high grade gliomas. Cancer Res., 55: 1941-1945, 1995.
22. Sonoda, Y., Yoshimoto, T., and Sekiya, T. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Oncogene, 11: 2145-2149, 1995.
23. INK4 or retinoblastoma protein (pRb), or amplification-associated overexpression of cdk4 is observed in distinct subsets of malignant glial tumors and cell lines. Cancer Res., 55: 4833-4836, 1995.
24. He, J., Allen, J., Collins, V., Allalunis-Tumer, M., Godbout, R., Day, R., III, and James, C. CDK4 amplification is an alternative mechanism to p16 gene homozygous deletion in glioma cell lines. Cancer Res., 54: 5804-5807, 1994.
25. INK4A, MTS1) and CDK4 genes have frequent mutations of the retinoblastoma gene. Oncogene, 13: 1065-1072, 1996.
26. Caldas, C., Hahn, S., da Costa, L., Redston, M., Schutte, M., Seymour, A., Weinstein, C., Hruban, R., Yeo, C., and Kern, S. Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat. Genet., 8: 27-32, 1994.
27. Mori, T., Miura, K., Aoki, T., Nishihira, T., Mori, S., and Nakamura, Y. Frequent somatic mutation of the MTS1/CDK4I (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinoma. Cancer Res., 54: 3396-3397, 1994.
28. Gonzalez-Zulueta, M., Bender, C., Yang, A., Nguyen, T., Beart, R., Van Tornout, J., and Jones, P. Methylation of the 5′ CpG island of the p16/CDKN2 tumor suppressor gene in normal and transformed human tissues correlates with gene silencing. Cancer Res., 55: 4531-4535, 1995.
29. Merlo, A., Herman, J., Mao, L., Lee, D., Gabrielson, E., Burger, P., Baylin, S., and Sidransky, D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers. Nat. Med., 1: 686-692, 1995.
30. Serrano, M., Lee, H., Chin, L., Cordon-Cardo, C., Beach, D., and DePinho, R. Role of the INK4a locus in tumor suppression and cell mortality. Cell, 85: 27-37, 1996.
31. Koh, J., Enders, G., Dynlacht, B., and Harlow, E. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition. Nature (Lond.), 375: 506-510, 1995.
32. Arap, W., Nishikawa, R., Furnari, F., Cavenee, W., and Huang, H. Replacement of the p16/CDKN2 gene suppresses human glioma cell growth. Cancer Res., 55: 1351-1354, 1995.
33. Lukas, J., Parry, D., Aagaard, L., Mann, D., Bartkova, J., Strauss, M., Peters, G., and Bartek, J. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Nature (Lond.), 375: 503-506, 1995.
34. ink4 requires functional retinoblastoma protein. Proc. Natl. Acad. Sci. USA, 92: 6289-6293, 1995.
35. INK4. Science (Washington DC), 267: 249-252, 1995.
36. INK4A expression on cell cycle arrest are determined by endogenous p16 and Rb status in human cancer cells. Oncogene, 16: 265-272, 1998.
37. INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status. Oncogene, 15: 495-503, 1997.
38. INK4A. Oncogene, 15: 505-514, 1997.
39. INK4A with human head and neck keratinocyte replicative senescence: relationship of dysfunction to immortality and neoplasia. Oncogene, 13: 561-568, 1996.
40. INK4a in replicative senescence of normal human fibroblasts. Proc. Natl. Acad. Sci. USA, 93: 13742-13747, 1996.
41. Hara, E., Smith, R., Parry, D., Tahara, H., Stone, S., and Peters, G. Regulation of p16CDKN2 expression and its implications for cell immortalization and senescence. Mol. Cell. Biol., 16: 859-867, 1996.
42. INK4B/MTS2, and p18 genes in primary and metastatic lung cancer. Cancer Res., 55: 1448-1451, 1995.
43. INK4B. Cancer Res., 56: 722-727, 1996.
44. Reynisdottir, I., Polyak, K., Iavarone, A., and Massague, J. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-β. Genes Dev., 9: 1831-1845, 1995.
45. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S., Puc, J., Miliaresis, C., Rodgers, L., McCombie, R., Bigner, S., Giovanella, B., Ittmann, M., Tycko, B., Hibshoosh, H., Wigler, M., and Parsons, R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
46. Steck, P., Pershouse, M., Jasser, S., Yung, W., Lin, H., Ligon, A., Langford, L., Baumgard, M., Hattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D., and Tavtigian, S. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
47. Van Meir, E., Kikuchi, T., Tada, M., Li, H., Diserens, A., Wojcik, B., Huang, H., Friedmann, T., de Tribolet, N., and Cavenee, W. Analysis of the p53 gene and its expression in human glioblastoma cells. Cancer Res., 54: 649-652, 1994.
48. Furnari, F., Lin, H., Huang, H., and Cavenee, W. Growth suppression of glioma cells by PTEN requires a functional phosphatase catalytic domain. Proc. Natl. Acad. Sci. USA,. 94: 12479-12484, 1997.
49. Nistér, M., and Westermark, B. Atlas of Human Tumor Cell Lines, pp. 17-42. San Diego, CA: Academic Press Inc., 1994.
50. INK4B, is initiated from an upstream GUG codon. Oncogene, 19: 1724-1728, 2000.
51. Dimri, G., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E., Linskens, M., Rubelj, I., Pereira-Smith, O., Peacocke, M., and Campisi, J. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA, 92: 9363-9367, 1995.
52. Shay, J. Ageing and cancer: are telomeres and telomerase the connection. Mol. Med. Today, 1: 378-384, 1995.
53. Fueyo, J., Gomez-Manzano, C., Yung, W., Clayman, G., Liu, T., Bruner, J., Levin, V., and Kyritsis, A. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells. Oncogene, 72: 103-110, 1996.
54. INK4a/CDKN2A in human glioma. Oncogene, 14: 603-609, 1997.
55. ARF, PTEN tumor suppressor genes in human glioma cell lines. Brain Pathol., 9: 469-479, 1999.
56. INK4 gene mediated by an adenovirus vector. Cancer Res., 55: 3250-3253, 1995.
57. Bartkova, J., Lukas, J., Guldberg, P., Alsner, J., Kirkin, A., Zeuthen, J., and Bartek, J. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Cancer Res., 56: 5475-5483, 1996.
58. INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death. Nat. Med., 3: 313-319, 1997.
59. WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines. Exp. Cell Res., 238: 51-62, 1998.
60. Stone, S., Dayananth, P., Jiang, P., Weaver-Feldhaus, J., Tavtigian, S., Cannon-Albright, L., and Kamb, A. Genomic structure, expression and mutational analysis of the p15 (MTS2) gene. Oncogene, 11: 987-991, 1995.
61. Sangfelt, O., Erickson, S., Einhorn, S., and Grander, D. Induction of Cip/Kip and Ink4 cyclin dependent kinase inhibitors by interferon-α in hematopoietic cell lines. Oncogene, 14: 415-423, 1997.
62. Hayflick, L., and Moorhead, P. The serial cultivation of human diploid cell strains. Exp. Cell Res., 25: 585-621, 1961.
63. Campisi, J. Replicative senescence: an old lives' tale? Cell, 84: 497-500, 1996.
64. McConnell, B., Starborg, M., Brookes, S., and Peters, G. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts. Curr. Biol., 8: 351-354, 1998.
65. INK4a. Cell, 88: 593-602, 1997.
66. Jacobs, J., Kieboom, K., Marino, S., DePinho, R., and van Lohuizen, M. The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (Lond.), 397: 164-168, 1999.
67. Erickson, S., Sangfelt, O., Heyman, M., Castro, J., Einhorn, S., and Grander, D. Involvement of the Ink4 proteins p16 and p15 in T-lymphocyte senescence. Oncogene, 77: 595-602, 1998.
68. de Lange, T. Telomeres and senescence: ending the debate. Science (Washington DC), 279: 334-335, 1998.
69. de Lange, T., and DePinho, R. Unlimited mileage from telomerase? Science (Washington DC), 283: 947-949, 1999.
70. Allsopp, R., Vaziri, H., Patterson, C., Goldstein, S., Younglai, E., Futcher, A., Greider, C., and Harley, C. Telomere length predicts replicative capacity of human fibroblasts. Proc. Natl. Acad. Sci. USA, 89: 10114-10118, 1992.
71. Bodnar, A., Ouellette, M., Frolkis, M., Holt, S., Chiu, C., Morin, G., Harley, C., Shay, J., Lichtsteiner, S., and Wright, W. Extension of life-span by introduction of telomerase into normal human cells. Science (Washington DC), 279: 349-352, 1998.
72. INK4a inactivation and telomerase activity are required to immortalize human epithelial cells. Nature (Lond.), 396: 84-88, 1998.
73. Xu, H., Zhou, Y., Ji, W., Perng, G., Kruzelock, R., Kong, C., Bast, R., Mills, G., Li, J., and Hu, S. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition. Oncogene, 15: 2589-2596, 1997.
74. McGrory, W., Bautista, D., and Graham, F. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5. Virology, 163: 614-617, 1988.
75. Bett, A., Krougliak, V., and Graham, F. DNA sequence of the deletion/ insertion in early region 3 of Ad5 dl309. Virus Res., 39: 75-82, 1995.
76. Ichimura, K., Schmidt, E., Yamaguchi, N., James, C., and Collins, V. A common region of homozygous deletion in malignant human gliomas lies between the IFNαω/u gene cluster and the D9S171 locus. Cancer Res., 54: 3127-3130, 1994.
77. Reifenberger, G., Liu, L., Ichimura, K., Schmidt, E., and Collins, V. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations. Cancer Res., 53: 2736-2739, 1993.
78. Reifenberger, G., Reifenberger, J., Ichimura, K., Meltzer, P., and Collins, V. Amplification of multiple genes from chromosomal region 12q13-14 in human malignant gliomas: preliminary mapping of the amplicons shows preferential involvement of CDK4, SAS, and MDM2. Cancer Res., 54: 4299-4303, 1994.
79. Hamelin, R., Jego, N., Laurent-Puig, P., Vidaud, M., and Thomas, G. Efficient screening of p53 mutations by denaturing gradient gel electrophoresis in colorectal tumors. Oncogene, 8: 2213-2220, 1993.
80. Andersson, A., and Pettersson, R. Targeting of a short peptide derived from the cytoplasmic tail of the Gl membrane glycoprotein of Uukuniemi virus (Bunyaviridae) to the Golgi complex. J. Virol., 72: 9585-9596, 1998.